https://de.marketscreener.com/kurs/aktie/NOVARTIS-AG-9364983/news/Novartis-erhalt-in-Kanada-Zulassung-fur-Augen-Software-fur-MS-Patienten-46283072/?utm_source=telegram&utm_medium=social&utm_campaign=share